Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.
Grunnet M, Sorensen JB.
Lung Cancer. 2012 May;76(2):138-43. doi: 10.1016/j.lungcan.2011.11.012. Epub 2011 Dec 6.
MicroRNA-495: a therapeutic and diagnostic tumor marker.
Maharati A, Tolue Ghasaban F, Akhlaghipour I, Taghehchian N, Zangouei AS, Moghbeli M.
J Mol Histol. 2023 Dec;54(6):559-578. doi: 10.1007/s10735-023-10159-0. Epub 2023 Sep 28.
Not easy to become a tumor marker.
Solnica B.
Pol Arch Med Wewn. 2016 Nov 30;126(11):845-846. doi: 10.20452/pamw.3699. Epub 2016 Nov 30.
CRD-BP as a Tumor Marker of Colorectal Cancer.
Fen-Xu, Jiang LH, Chen-Fu, Feng WW, Zhou CJ.
Anticancer Agents Med Chem. 2024;24(3):169-176. doi: 10.2174/0118715206256546231108095912.
Integrin beta4 as a Potential Diagnostic and Therapeutic Tumor Marker.
Yang H, Xu Z, Peng Y, Wang J, Xiang Y.
Biomolecules. 2021 Aug 12;11(8):1197. doi: 10.3390/biom11081197.
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.
Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG.
J Natl Cancer Inst. 2018 Aug 1;110(8):803-811. doi: 10.1093/jnci/djy088.
Lung cancer tumor marker analysis: A clinical laboratory perspective.
van Rossum HH, Holdenrieder S.
Tumour Biol. 2024;46(s1):S9-S14. doi: 10.3233/TUB-240005.
Aurora-A kinase: potential tumor marker of osteosarcoma.
Zhu X, Mei J, Wang Z.
J Cancer Res Ther. 2014 Nov;10 Suppl:C102-7. doi: 10.4103/0973-1482.145804.
CD44 as a potential diagnostic tumor marker.
Basakran NS.
Saudi Med J. 2015 Mar;36(3):273-9. doi: 10.15537/smj.2015.3.9622.
[Progress in Research on the Novel Tumor Marker circRNA].
Xu H, Fang MD, Li C, Liu C, Ren J, Zhang YM.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021 Jun 30;43(3):435-444. doi: 10.3881/j.issn.1000-503X.12920.
